Cara Therapeutics (CARA) stock forecast for 2022 – 2027

Are you interested in Cara Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CARA stock price in 2022-2027. Is CARA a good long term stock? When should I take profit in Cara Therapeutics stock? Buy or sell stock? Will CARA stock price go up? What are analysts’ forecasts for CARA stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CARA stock returns are also predicted based on historical data.

According to our research, CARA stock is a bad long-term investment. CARA share price has been in a bear cycle for the past year. Cara Therapeutics, Inc. stock trend is negative.

Cara Therapeutics company info

Industry Biotechnology
Address 4 Stamford Plaza, Stamford, CT, 06902, United States
Website https://www.caratherapeutics.com

Forecasting

52 Week High: 12.9723 USD
52 Week Low: 8.96544 USD
1 Year Forecast: 9.98613 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 619.05M
52 Week Change: -7.114%
52 Week High: 29.65 USD
52 Week Low: 10.63 USD
Beta: 0.693225
50 Day Moving Average: 12.02
90 Day Moving Average: 13.153
200 Day Moving Average: 13.66
Resistance Level: 12.173
Pivot Point: 11.6606
Support Level: 10.7296
Enterprise Value: 527,059,328
Forward P/E: -7.82
Forward EPS: -1.41
Profit Margin: 17.76%
Shares Outstanding: 53,458,700
EBITDA: 22.94
Held Percent Institutions: 58.20%
PEG Ratio (5Y): 0
Trailing EPS: 0.48

Cara Therapeutics stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Cara Therapeutics Stock Forecast for 2022

March 2022 11.22 11.11 -0.98%
April 2022 12.12 11.22 -7.43%
May 2022 10.1 10.2 0.99%
June 2022 10.1 12.24 21.19%
July 2022 12 12.24 2%
August 2022 12.12 10.78 -11.06%
September 2022 11.22 10 -10.87%
October 2022 10.1 10.2 0.99%
November 2022 10.1 9.8 -2.97%
December 2022 10.1 9.18 -9.11%

Cara Therapeutics Stock Forecast for 2023

January 2023 9 9.09 1%
February 2023 10 9.8 -2%
March 2023 10 10 0%
April 2023 11 10 -9.09%
May 2023 8.82 9 2.04%
June 2023 9.09 11.22 23.43%
July 2023 10.78 11 2.04%
August 2023 11 10.1 -8.18%
September 2023 10.1 8.91 -11.78%
October 2023 9 9.09 1%
November 2023 9.09 9.18 0.99%
December 2023 8.91 7 -21.44%

Cara Therapeutics Stock Forecast for 2024

January 2024 7.84 7.92 1.02%
February 2024 8.08 9 11.39%
March 2024 8.82 9 2.04%
April 2024 9.09 7.92 -12.87%
May 2024 8.08 7.84 -2.97%
June 2024 8.08 9 11.39%
July 2024 9.9 9 -9.09%
August 2024 8.82 9 2.04%
September 2024 8.91 7.92 -11.11%
October 2024 8 6.93 -13.38%
November 2024 6.86 8.08 17.78%
December 2024 6.86 6.06 -11.66%

Cara Therapeutics Stock Forecast for 2025

January 2025 5.88 7.14 21.43%
February 2025 7.07 7.84 10.89%
March 2025 8.08 7.92 -1.98%
April 2025 8.08 6.93 -14.23%
May 2025 6.93 6.86 -1.01%
June 2025 6.93 7.92 14.29%
July 2025 7.84 8.08 3.06%
August 2025 8.08 7 -13.37%
September 2025 7.84 7.07 -9.82%
October 2025 7 5.88 -16%
November 2025 5.88 6 2.04%
December 2025 5.88 4.95 -15.82%

Cara Therapeutics Stock Forecast for 2026

January 2026 5.05 5.88 16.44%
February 2026 5.88 5.94 1.02%
March 2026 5.94 7.14 20.2%
April 2026 6.86 6 -12.54%
May 2026 4.9 5.1 4.08%
June 2026 6.12 7.14 16.67%
July 2026 6.86 7.14 4.08%
August 2026 7.14 6 -15.97%
September 2026 6.12 6.12 0%
October 2026 5 5 0%
November 2026 5.05 4.9 -2.97%
December 2026 4.9 3.96 -19.18%

Cara Therapeutics Stock Forecast for 2027

January 2027 3.92 4 2.04%